Jiang QH, Chen Y, Wang AX. Clinicopathologic significance of SH2B1 and RhoA expression in esophageal cancer.
Shijie Huaren Xiaohua Zazhi 2013;
21:3706-3709. [DOI:
10.11569/wcjd.v21.i33.3706]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To detect the expression of SH2B1 and RhoA in esophageal cancer and to analyze their clinicopathologic significance.
METHODS: The expression of SH2B1 and RhoA in esophageal cancer tissues and normal tissues was detected by immunohistochemistry.
RESULTS: The positive rates of SH2B1 and RhoA expression were significantly higher in esophageal cancer tissues than in the normal tissues (84.2% vs 33.6%, P = 0.028; 79.8% vs 22.4%, P = 0.022). SH2B1 and RhoA expression levels were correlated with depth of invasion, TNM stage and lymph node metastasis (all P < 0.05), but not with gender, age, tumor type or histological grade (all P > 0.05).
CONCLUSION: High expression of SH2B1 and RhoA is detectable in esophageal cancer tissues. The expression of SH2B1 and RhoA has close associations with clinicopathologic characteristics of esophageal cancer.
Collapse